LLC-PK1 Kidney Cytotoxicity Assay: Version 1.3
- PMID: 39013067
- Bookshelf ID: NBK604964
- DOI: 10.17917/Q6EC-XC97
LLC-PK1 Kidney Cytotoxicity Assay: Version 1.3
Excerpt
This protocol describes the cytotoxicity testing of nanoparticle formulations porcine proximal tubule cells (LLC-PK1), as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes two methods for estimation of cytotoxicity, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release [–2].
Sections
References
-
- ISO 10993-5, Biological evaluation of medical devices: Part 5, Tests for in vitro cytotoxicity.
-
- F1903 – 98, Standard Practice for Testing for Biological Responses to Particles in vitro.
-
- Alley, et al.. (1988) Cancer Res. 48:589–601. - PubMed
-
- Decker, T. & Lohmann-Matthes, M.L. (1988) J. Immunol Methods 15:61–69. - PubMed
-
- Korzeniewski, C. & Callewaert, D.M. (1983) J. Immunol Methods 64:313–320. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous